Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Recordati Industria Chimica e Farmaceutica S.p.A. logo
REC.MI
Recordati Industria Chimica e Farmaceutica S.p.A.
13:10:36
50.45 €
0.0000 (%0.00)
Previous Close: 50.55
Day Low₺50.45
Day High₺50.75
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

REC.MI: Recordati Industria Chimica e Farmaceutica S.p.A. Financials

Recordati Industria Chimica e Farmaceutica S.p.A. Income Statement

Total revenue
Net income
Gross margin TTM
68.27%
Operating margin TTM
27.49%
Net profit margin TTM
16.94%
Return on investment TTM
23.11%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue2,618,383,0002,341,559,0002,082,331,0001,853,307,000
Operating income719,739,000638,900,000558,008,000437,326,000
Net income443,624,000416,508,000389,214,000312,336,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue2,618,383,0002,341,559,0002,082,331,0001,853,307,000
Cost of revenue830,704,000741,287,000659,707,000566,737,000
Gross profit1,787,679,0001,600,272,0001,422,624,0001,286,570,000
Research and development expenses340,952,000286,026,000255,747,000220,102,000
General and administrative expenses168,015,000156,648,000128,253,000109,493,000
Selling and marketing expenses558,973,000497,728,000472,857,000462,665,000
Selling, general and administrative expenses726,988,000654,376,000601,110,000572,158,000
Other expenses021,013,0007,759,000497,000
Operating expenses1,067,940,000961,415,000856,857,000792,260,000
Cost and expenses1,898,644,0001,702,700,0001,524,323,0001,358,997,000
Net interest income-99,287,000-81,546,000-74,455,000-32,303,000
Interest income0000
Interest expense99,287,00081,546,00074,455,00032,303,000
Depreciation and amortization206,435,000167,025,000142,670,000125,756,000
EBITDA886,996,000795,370,000708,161,000559,349,000
EBIT680,561,000628,345,000565,491,000433,593,000
Non-operating income (excl. interest)39,178,00010,555,000-7,483,0003,733,000
Operating income719,739,000638,900,000558,008,000437,326,000
Total other income/expenses (net)-138,465,000-91,716,000-66,972,000-35,891,000
Income before tax581,274,000547,184,000491,036,000401,435,000
Income tax expense137,650,000130,676,000101,822,00089,099,000
Net income from continuing operations443,624,000416,508,000389,214,000312,336,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income443,624,000416,508,000389,214,000312,336,000
Net income deductions08,00000
Bottom line net income443,624,000416,500,000389,214,000312,336,000
EPS2222
Diluted EPS2221
Weighted average shares outstanding205,483,735206,316,241205,634,136205,582,127
Weighted average diluted shares outstanding209,157,944209,090,361209,142,396209,060,240

Recordati Industria Chimica e Farmaceutica S.p.A. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
2,092,395,999%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets5,252,275,0005,134,455,0004,208,131,0003,998,823,000
Total liabilities3,332,503,0003,257,646,0002,521,739,0002,452,575,000
Total equity1,919,772,0001,876,809,0001,686,392,0001,546,248,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents428,824,000322,423,000221,812,000284,734,000
Short-term investments0000
Cash and short-term investments428,824,000322,423,000221,812,000284,734,000
Net receivables590,051,000516,743,000445,193,000374,708,000
Accounts receivable570,154,000516,743,000445,193,000361,898,000
Other receivables19,897,00026,638,00024,097,00012,810,000
Inventory539,804,000506,447,000404,831,000424,080,000
Prepaid expenses713,0003,369,000076,385,000
Other current assets118,513,000142,418,000130,404,00038,990,000
Total current assets1,677,905,0001,491,400,0001,202,240,0001,186,086,000
Property, plant and equipment (net)222,324,000206,700,000178,657,000159,184,000
Goodwill795,680,000797,078,000778,350,000780,057,000
Intangible assets2,393,448,0002,513,159,0001,938,197,0001,758,173,000
Goodwill and intangible assets3,189,128,0003,310,237,0002,716,547,0002,538,230,000
Long-term investments17,444,00017,385,00021,555,00028,871,000
Tax assets136,415,00094,527,00076,674,00076,895,000
Other non-current assets9,059,00014,206,00012,458,0009,556,000
Total non-current assets3,574,370,0003,643,055,0003,005,891,0002,812,736,000
Other assets0001,000
Total assets5,252,275,0005,134,455,0004,208,131,0003,998,823,000
Total payables588,559,000494,284,000331,089,000258,318,000
Accounts payable345,183,000296,698,000263,979,000224,703,000
Other payables243,376,000197,586,00067,110,00067,230,000
Accrued expenses00083,924,000
Short-term debt337,190,000305,554,00099,932,000383,103,000
Capital lease obligations (current)010,696,00010,249,0009,237,000
Tax payables80,572,00093,941,00067,110,00033,615,000
Deferred revenue0000
Other current liabilities126,933,000118,525,000561,806,000189,161,000
Total current liabilities1,052,682,000929,059,0001,003,076,000923,743,000
Long-term debt2,092,395,9992,135,697,0001,325,579,0001,319,978,000
Capital lease obligations (non-current)37,900,00038,113,00027,637,00021,571,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)129,687,000133,422,000144,208,000167,865,000
Other non-current liabilities19,838,00021,355,00021,239,00019,418,000
Total non-current liabilities2,279,821,0002,328,587,0001,518,663,0001,528,832,000
Other liabilities0000
Capital lease obligations37,900,00048,809,00037,886,00030,808,000
Total liabilities3,332,503,0003,257,646,0002,521,739,0002,452,575,000
Treasury stock-239,379,000-131,570,000-127,970,000-149,559,000
Preferred stock0000
Common stock26,141,00026,141,00026,141,00026,141,000
Retained earnings2,452,631,0002,115,797,9992,025,665,0001,836,435,000
Additional paid-in capital83,719,00083,719,00083,719,00083,719,000
Accumulated other comprehensive income/loss0-217,278,9990-137,509,000
Other stockholders' equity-403,340,000-336,028,000-321,163,000-500,976,000
Total stockholders' equity1,919,772,0001,876,809,0001,686,392,0001,546,248,000
Total equity1,919,772,0001,876,809,0001,686,392,0001,546,248,000
Minority interest0000
Total liabilities and total equity5,252,275,0005,134,455,0004,208,131,0003,998,823,000
Total investments17,444,00017,385,00021,555,00028,871,000
Total debt2,467,485,9992,490,060,0001,463,397,0001,716,520,000
Net debt2,038,661,999-299,578,0001,241,585,0001,431,786,000

Recordati Industria Chimica e Farmaceutica S.p.A. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations596,897,000569,918,000485,319,000461,691,000
Cash from investing-80,836,000-844,942,000-379,618,000-767,124,000
Cash from financing-407,016,000372,114,000-168,914,000341,277,000
Net change in cash106,401,000100,611,000-62,922,00040,156,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income443,624,000416,508,000389,214,000312,336,000
Depreciation and amortization206,435,000167,025,000142,670,000125,756,000
Deferred income tax0000
Stock-based compensation16,545,00016,520,00010,870,0008,251,000
Change in working capital-148,206,000-112,519,000-110,633,000-61,387,000
Accounts receivable-63,122,000-86,782,000-100,565,000-21,175,000
Inventory-134,836,000-55,758,000-50,337,000-65,801,000
Accounts payable49,752,00030,021,00040,269,00025,589,000
Other working capital0000
Other non-cash items78,499,00082,384,00053,198,00076,735,000
Net cash from operating activities596,897,000569,918,000485,319,000461,691,000
Investments in property, plant and equipment-39,444,000-34,800,000-29,687,000-96,339,000
Acquisitions (net)-2,660,00000-673,259,000
Purchases of investments0000
Sales/maturities of investments0000
Other investing activities-38,732,000-810,142,000-349,931,0002,474,000
Net cash from investing activities-80,836,000-844,942,000-379,618,000-767,124,000
Net debt issuance-15,691,000663,766,00079,829,000620,723,000
Long-term net debt issuance-15,573,000741,461,00067,377,000553,427,000
Short-term net debt issuance-118,000-77,695,00012,452,00067,296,000
Net stock issuance-112,494,000-26,400,000-22,710,000-38,619,000
Net common stock issuance-112,494,000-26,353,0007,387,000-38,619,000
Common stock issuance44,561,00092,670,00030,097,00013,648,000
Common stock repurchased-157,055,000-119,023,000-22,710,000-52,267,000
Net preferred stock issuance0-47,000-30,097,0000
Net dividends paid-267,556,000-253,718,000-245,958,000-230,602,000
Common dividends paid-267,556,000-253,718,000-245,958,000-230,602,000
Preferred dividends paid0-18,00000
Other financing activities-11,275,000-11,534,00019,925,000-10,225,000
Net cash from financing activities-407,016,000372,114,000-168,914,000341,277,000
Effect of FX changes on cash-2,644,0003,521,000291,0004,312,000
Net change in cash106,401,000100,611,000-62,922,00040,156,000
Cash at end of period428,824,000322,423,000221,812,000284,734,000
Cash at beginning of period322,423,000221,812,000284,734,000244,578,000
Operating cash flow596,897,000569,918,000485,319,000461,691,000
Capital expenditure-85,124,000-36,647,000-383,264,000-96,339,000
Free cash flow511,773,000535,100,000102,055,000365,352,000
Income taxes paid0000
Interest paid0000